4-3492904-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS1

The NM_173660.5(DOK7):​c.918C>T​(p.Ala306Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000419 in 1,578,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A306A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0014 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00032 ( 0 hom. )

Consequence

DOK7
NM_173660.5 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -0.569

Publications

3 publications found
Variant links:
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
DOK7 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 4-3492904-C-T is Benign according to our data. Variant chr4-3492904-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 198627.
BP7
Synonymous conserved (PhyloP=-0.569 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00139 (212/152294) while in subpopulation AFR AF = 0.00327 (136/41576). AF 95% confidence interval is 0.00282. There are 0 homozygotes in GnomAd4. There are 124 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_173660.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOK7
NM_173660.5
MANE Select
c.918C>Tp.Ala306Ala
synonymous
Exon 7 of 7NP_775931.3
DOK7
NM_001256896.2
c.-13C>T
5_prime_UTR_premature_start_codon_gain
Exon 4 of 4NP_001243825.1
DOK7
NM_001301071.2
c.918C>Tp.Ala306Ala
synonymous
Exon 7 of 10NP_001288000.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOK7
ENST00000340083.6
TSL:1 MANE Select
c.918C>Tp.Ala306Ala
synonymous
Exon 7 of 7ENSP00000344432.5
DOK7
ENST00000515886.5
TSL:2
c.-13C>T
5_prime_UTR_premature_start_codon_gain
Exon 4 of 4ENSP00000492194.1
DOK7
ENST00000643608.1
c.486C>Tp.Ala162Ala
synonymous
Exon 5 of 8ENSP00000495701.1

Frequencies

GnomAD3 genomes
AF:
0.00139
AC:
211
AN:
152176
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00326
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00527
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000684
AC:
127
AN:
185582
AF XY:
0.000613
show subpopulations
Gnomad AFR exome
AF:
0.00341
Gnomad AMR exome
AF:
0.000106
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000147
Gnomad FIN exome
AF:
0.00477
Gnomad NFE exome
AF:
0.000151
Gnomad OTH exome
AF:
0.00102
GnomAD4 exome
AF:
0.000316
AC:
450
AN:
1425986
Hom.:
0
Cov.:
110
AF XY:
0.000324
AC XY:
229
AN XY:
706774
show subpopulations
African (AFR)
AF:
0.00290
AC:
95
AN:
32718
American (AMR)
AF:
0.0000755
AC:
3
AN:
39726
Ashkenazi Jewish (ASJ)
AF:
0.0000392
AC:
1
AN:
25534
East Asian (EAS)
AF:
0.000240
AC:
9
AN:
37534
South Asian (SAS)
AF:
0.000145
AC:
12
AN:
82516
European-Finnish (FIN)
AF:
0.00374
AC:
172
AN:
46042
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5730
European-Non Finnish (NFE)
AF:
0.000118
AC:
130
AN:
1097072
Other (OTH)
AF:
0.000440
AC:
26
AN:
59114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00139
AC:
212
AN:
152294
Hom.:
0
Cov.:
34
AF XY:
0.00167
AC XY:
124
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00327
AC:
136
AN:
41576
American (AMR)
AF:
0.000261
AC:
4
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00527
AC:
56
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
67990
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000718
Hom.:
0
Bravo
AF:
0.00115

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Jul 06, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 06, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
4.8
DANN
Benign
0.71
PhyloP100
-0.57
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141947707; hg19: chr4-3494631; API